image
Healthcare - Medical - Care Facilities - NYSE - US
$ 134.97
-4.66 %
$ 10.8 B
Market Cap
12.44
P/E
1. INTRINSIC VALUE

This DCF valuation model was last updated on Apr, 23, 2025.

The intrinsic value of one DVA stock under the worst case scenario is HIDDEN Compared to the current market price of 135 USD, DaVita Inc. is HIDDEN

This DCF valuation model was last updated on Apr, 23, 2025.

The intrinsic value of one DVA stock under the base case scenario is HIDDEN Compared to the current market price of 135 USD, DaVita Inc. is HIDDEN

This DCF valuation model was last updated on Apr, 23, 2025.

The intrinsic value of one DVA stock under the best case scenario is HIDDEN Compared to the current market price of 135 USD, DaVita Inc. is HIDDEN

2. FUNDAMENTAL ANALYSIS

Price Chart DVA

image
$180.0$180.0$175.0$175.0$170.0$170.0$165.0$165.0$160.0$160.0$155.0$155.0$150.0$150.0$145.0$145.0$140.0$140.0$135.0$135.0$130.0$130.0Nov '24Nov '2415 Nov15 NovDec '24Dec '2415 Dec15 DecJan '25Jan '2515 Jan15 JanFeb '25Feb '2515 Feb15 FebMar '25Mar '2515 Mar15 MarApr '25Apr '2515 Apr15 Apr
FINANCIALS
12.8 B REVENUE
5.56%
2.09 B OPERATING INCOME
30.43%
1.25 B NET INCOME
80.86%
2.02 B OPERATING CASH FLOW
-1.80%
-771 M INVESTING CASH FLOW
0.05%
-817 M FINANCING CASH FLOW
30.21%
3.29 B REVENUE
0.95%
565 M OPERATING INCOME
5.70%
349 M NET INCOME
18.08%
548 M OPERATING CASH FLOW
-32.43%
-248 M INVESTING CASH FLOW
-72.82%
-565 M FINANCING CASH FLOW
-5103.53%
Balance Sheet DaVita Inc.
image
Current Assets 3.75 B
Cash & Short-Term Investments 846 M
Receivables 2.53 B
Other Current Assets 370 M
Non-Current Assets 13.7 B
Long-Term Investments 337 M
PP&E 5.74 B
Other Non-Current Assets 7.57 B
4.86 %14.54 %33.02 %43.52 %Total Assets$17.4b
Current Liabilities 2.97 B
Accounts Payable 547 M
Short-Term Debt 0
Other Current Liabilities 2.43 B
Non-Current Liabilities 12.2 B
Long-Term Debt 11.4 B
Other Non-Current Liabilities 835 M
3.60 %15.97 %74.93 %5.50 %Total Liabilities$15.2b
EFFICIENCY
Earnings Waterfall DaVita Inc.
image
Revenue 12.8 B
Cost Of Revenue 0
Gross Profit 12.8 B
Operating Expenses 10.7 B
Operating Income 2.09 B
Other Expenses 840 M
Net Income 1.25 B
14b14b12b12b10b10b8b8b6b6b4b4b2b2b0013b013b(11b)2b(840m)1bRevenueRevenueCost Of RevenueCost Of RevenueGross ProfitGross ProfitOperating ExpensesOperating ExpensesOperating IncomeOperating IncomeOther ExpensesOther ExpensesNet IncomeNet Income
RATIOS
100.00% GROSS MARGIN
100.00%
16.31% OPERATING MARGIN
16.31%
7.31% NET MARGIN
7.31%
773.06% ROE
773.06%
5.42% ROA
5.42%
11.84% ROIC
11.84%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis DaVita Inc.
image
2b2b1b1b1b1b1b1b800m800m600m600m400m400m200m200m0020162016201720172018201820192019202020202021202120222022202320232024202420252025
Net Income 1.25 B
Depreciation & Amortization 724 M
Capital Expenditures -555 M
Stock-Based Compensation 103 M
Change in Working Capital 0
Others 2.49 M
Free Cash Flow 1.47 B
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets DaVita Inc.
image
Wall Street analysts predict an average 1-year price target for DVA of $160 , with forecasts ranging from a low of $145 to a high of $184 .
DVA Lowest Price Target Wall Street Target
145 USD 7.43%
DVA Average Price Target Wall Street Target
160 USD 18.30%
DVA Highest Price Target Wall Street Target
184 USD 36.33%
Price
Max Price Target
Min Price Target
Average Price Target
190190180180170170160160150150140140130130Jun '24Jun '24Jul '24Jul '24Aug '24Aug '24Oct '24Oct '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26Apr '26Apr '26
4. DIVIDEND ANALYSIS
5. COMPETITION
slide 2 of 12
6. Ownership
Insider Ownership DaVita Inc.
image
Sold
0-3 MONTHS
148 M USD 1
3-6 MONTHS
0 USD 0
6-9 MONTHS
34.3 M USD 4
9-12 MONTHS
698 K USD 1
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
7. News
DaVita HealthCare (DVA) Ascends But Remains Behind Market: Some Facts to Note In the latest trading session, DaVita HealthCare (DVA) closed at $134.97, marking a +1.1% move from the previous day. zacks.com - 1 week ago
3 No-Brainer Warren Buffett Stocks to Buy Right Now In uncertain markets, it pays to follow proven wisdom -- and few investors have a track record as legendary as Warren Buffett. Since taking over Berkshire Hathaway (NYSE: BRK.A) (NYSE: BRK.B) in 1965, Buffett has weathered every market storm and consistently outperformed market benchmarks. fool.com - 1 week ago
Why DaVita Stock Got Rocked This Week We're in an age when the threat of cyberattacks is real and substantial. Confirming this, veteran healthcare company DaVita (DVA -0.91%) suffered a hacker ambush in recent days, a situation that spooked many investors. fool.com - 2 weeks ago
DaVita HealthCare (DVA) Stock Declines While Market Improves: Some Information for Investors DaVita HealthCare (DVA) concluded the recent trading session at $140.03, signifying a -1.04% move from its prior day's close. zacks.com - 2 weeks ago
DaVita Says Ransomware Attack Affecting Some Operations DaVita has been hit with a ransomware attack that has affected some of the kidney-care company's operations. wsj.com - 2 weeks ago
Dialysis firm DaVita hit by ransomware attack DaVita said on Monday it had become aware of a ransomware incident that has encrypted some elements of its network, prompting the dialysis firm to implement measures to limit the effect of the breach. reuters.com - 2 weeks ago
4 Stocks to Watch in a Dynamic Outpatient Home Health Industry An aging global population and AI dominance are likely to drive the Zacks Medical - Outpatient and Home Healthcare industry despite the macroeconomic challenges. DVA, EHC, OPCH and ADUS are well-poised to gain. zacks.com - 3 weeks ago
DaVita HealthCare (DVA) Stock Falls Amid Market Uptick: What Investors Need to Know The latest trading day saw DaVita HealthCare (DVA) settling at $151.91, representing a -0.69% change from its previous close. zacks.com - 1 month ago
DaVita HealthCare (DVA) Rises As Market Takes a Dip: Key Facts In the most recent trading session, DaVita HealthCare (DVA) closed at $151.37, indicating a +0.39% shift from the previous trading day. zacks.com - 1 month ago
DaVita Stock Declines 1.2% in 3 Months: Here's How to Play DVA's stable core business and global expansion are offset by rising labor costs and declining commercial mix, creating a mixed outlook for investors. zacks.com - 1 month ago
DaVita HealthCare (DVA) Exceeds Market Returns: Some Facts to Consider DaVita HealthCare (DVA) reachead $150.78 at the closing of the latest trading day, reflecting a +0.25% change compared to its last close. zacks.com - 1 month ago
DaVita HealthCare (DVA) Increases Yet Falls Behind Market: What Investors Need to Know The latest trading day saw DaVita HealthCare (DVA) settling at $149.83, representing a +0.31% change from its previous close. zacks.com - 1 month ago
8. Profile Summary

DaVita Inc. DVA

image
COUNTRY US
INDUSTRY Medical - Care Facilities
MARKET CAP $ 10.8 B
Dividend Yield 0.00%
Description DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company provides disease management services to 16,000 patients in risk-based integrated care arrangements and 7,000 patients in other integrated care arrangements; vascular access services; clinical research programs; physician services; and comprehensive kidney care services. As of December 31, 2021, it provided dialysis and administrative services in the United States through a network of 2,815 outpatient dialysis centers serving approximately 203,100 patients; and operated 339 outpatient dialysis centers located in 10 countries outside of the United States serving approximately 39,900 patients. Further, the company provides acute inpatient dialysis services in approximately 850 hospitals and related laboratory services in the United States. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.
Contact 2000 16th Street, Denver, CO, 80202 https://www.davita.com
IPO Date Oct. 31, 1995
Employees 76000
Officers Mr. Misha Palecek Chief Transformation Officer of U.S. Kidney Care Business Nic Eliason Group Vice President of Investor Relations Ms. Madhu Narasimhan Chief Information Officer Mr. David Maughan Chief Operating Officer Ms. Kathleen Alyce Waters Chief Legal & Public Affairs Officer Mr. Christopher Michael Berry CPA Group Vice President & Chief Accounting Officer Mr. James O. Hearty Chief Compliance Officer Mr. Javier J. Rodriguez Chief Executive Officer & Executive Director Ms. Jessica Hergenreter Chief People Officer Mr. Joel Ackerman Chief Financial Officer & Treasurer